Synergistic interactions and optimal sequencing of chemotherapy and immunotherapy in cancer treatment.
Saved in:
| Title: | Synergistic interactions and optimal sequencing of chemotherapy and immunotherapy in cancer treatment. |
|---|---|
| Authors: | Fan X; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.; School of Pharmacy, Yunnan University, Kunming, 650500, China., Ye H; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China., Qian W; Department of Bone and Soft Tissue Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, 310022, China., Li T; Department of Bone and Soft Tissue Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, 310022, China., Ding X; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.; College of Notoginseng Medicine, Wenshan University, 663099, Yunnan, Wenshan, China., Fang M; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Department of Head and Neck and Rare Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, China., Cao J; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Department of Head and Neck and Rare Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, China. caojun@zjcc.org.cn. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 Feb 23; Vol. 96 (1). Date of Electronic Publication: 2026 Feb 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41729286 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Synergistic interactions and optimal sequencing of chemotherapy and immunotherapy in cancer treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fan+X%22">Fan X</searchLink>; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.; School of Pharmacy, Yunnan University, Kunming, 650500, China.<br /><searchLink fieldCode="AU" term="%22Ye+H%22">Ye H</searchLink>; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.<br /><searchLink fieldCode="AU" term="%22Qian+W%22">Qian W</searchLink>; Department of Bone and Soft Tissue Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, 310022, China.<br /><searchLink fieldCode="AU" term="%22Li+T%22">Li T</searchLink>; Department of Bone and Soft Tissue Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, 310022, China.<br /><searchLink fieldCode="AU" term="%22Ding+X%22">Ding X</searchLink>; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.; College of Notoginseng Medicine, Wenshan University, 663099, Yunnan, Wenshan, China.<br /><searchLink fieldCode="AU" term="%22Fang+M%22">Fang M</searchLink>; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Department of Head and Neck and Rare Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, China.<br /><searchLink fieldCode="AU" term="%22Cao+J%22">Cao J</searchLink>; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Department of Head and Neck and Rare Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, China. caojun@zjcc.org.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2026 Feb 23; Vol. 96 (1). <i>Date of Electronic Publication: </i>2026 Feb 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41729286 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-025-04817-1 Languages: – Code: eng Text: English Titles: – TitleFull: Synergistic interactions and optimal sequencing of chemotherapy and immunotherapy in cancer treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fan X – PersonEntity: Name: NameFull: Ye H – PersonEntity: Name: NameFull: Qian W – PersonEntity: Name: NameFull: Li T – PersonEntity: Name: NameFull: Ding X – PersonEntity: Name: NameFull: Fang M – PersonEntity: Name: NameFull: Cao J IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 02 Text: 2026 Feb 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0843 Numbering: – Type: volume Value: 96 – Type: issue Value: 1 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |
